Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part)
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2014
|
| In: |
Annals of oncology
Year: 2014, Volume: 25, Issue: 3, Pages: 682-688 |
| ISSN: | 1569-8041 |
| DOI: | 10.1093/annonc/mdu003 |
| Online Access: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1093/annonc/mdu003
|
| Author Notes: | J.B. Vermorken, F. Peyrade, J. Krauss, R. Mesía, E. Remenar, T.C. Gauler, U. Keilholz, J.P. Delord, P. Schafhausen, J. Erfán, T.H. Brümmendorf, L. Iglesias, U. Bethe, C. Hicking and P.M. Clement |
| Item Description: | Gesehen am 23.02.2016 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 1569-8041 |
| DOI: | 10.1093/annonc/mdu003 |